Assert-IQ vs Loss of Pulse Detection

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Assert-IQ
by Abbott Medical
VS
Loss of Pulse Detection
by Fitbit

AI Verdict

Assert-IQ is an insertable cardiac monitor designed for long-term, continuous clinical diagnosis and management of arrhythmias by healthcare professionals. Conversely, Fitbit's Loss of Pulse Detection is a feature on consumer wearable devices focused on immediate emergency alerting for individual users experiencing a potential loss of pulse. While both address cardiac health, their distinct deployment methods and primary objectives make them suitable for different use cases and target audiences.

Choose Assert-IQ if…

Choose Assert-IQ if your cardiology clinic or health system requires a comprehensive, long-term solution for diagnosing and managing patients with suspected chronic or intermittent heart rhythm disorders. This system is ideal for continuous, in-depth cardiac monitoring over several years, providing clinicians with detailed arrhythmia detection and remote data for precise diagnostic and treatment planning.

View Assert-IQ →

Choose Loss of Pulse Detection if…

Choose Fitbit's Loss of Pulse Detection if you are an individual seeking an immediate, personal safety net for sudden, critical cardiac events. This feature is best suited for users of compatible smartwatches who desire automatic detection of a potential loss of pulse and the ability to automatically alert emergency services with location information if unresponsive.

View Loss of Pulse Detection →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Assert-IQ Loss of Pulse Detection
Pricing Enterprise Unknown
Deployment Hybrid Unknown
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Loss of Pulse Detection

Tool B, integrated into a consumer wearable, offers a more immediate and intuitive user experience for the general public, requiring no medical procedure for activation. Its core function is automatic, leveraging familiar device interactions for ease of use.

Clinical Value

Assert-IQ

Tool A provides long-term, continuous, and detailed cardiac monitoring for comprehensive arrhythmia diagnosis and management, offering deep insights for cardiologists over extended periods. This offers a broader and more sustained clinical value for ongoing patient care and physician decision-making.

Pricing & Value

Loss of Pulse Detection

Tool B is included as a feature with compatible Fitbit/Pixel devices, meaning its cost is bundled with a consumer-grade wearable, offering high value for individual users. Tool A, with its enterprise pricing requiring direct contact, implies a significant institutional investment.

Enterprise Readiness

Assert-IQ

Tool A is explicitly designed for enterprise deployment, targeting large health systems and cardiology clinics with a hybrid deployment model and data export capabilities. It is backed by a major medical device company with established enterprise sales and support.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. Tool A pushes the boundaries of long-term implantable cardiac monitoring with extended battery life and advanced algorithms. Tool B innovatively applies consumer technology for immediate, life-saving emergency intervention.

Support & Docs

Assert-IQ

Tool A, backed by Abbott Medical, a long-established medical device company, is expected to have comprehensive clinical support, technical documentation, and training programs tailored for healthcare professionals and institutions. Tool B, from Fitbit/Google, would offer robust consumer-grade support, but likely less specialized for complex medical workflows.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Assert-IQ Loss of Pulse Detection
Product Name Assert-IQ Loss of Pulse Detection
Company Abbott Medical Fitbit
Primary Function Provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. Uses PPG and accelerometry to detect a potential loss of pulse and can automatically alert emergency services if the user is unresponsive.
Key Feature: Monitoring Mechanism Long-term continuous cardiac monitoring (up to 6 years) with advanced arrhythmia detection algorithms. Automatic loss of pulse detection utilizing PPG and accelerometry sensors.
Key Feature: Alerting/Action Proactive clinician alerts and patient activator for symptom logging. Automated emergency service calling if unresponsive and shares location with emergency services.
Target User/Integration Large health systems, hospitals, cardiology clinics Integrated with compatible smartwatches (e.g., Pixel Watch 3)

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and Loss of Pulse Detection.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Assert-IQu2122 is designed for long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. Fitbit's Loss of Pulse Detection is an FDA-cleared feature on compatible wearable devices that detects a potential loss of pulse and can automatically alert emergency services if the user is unresponsive.
Assert-IQu2122 is an Insertable Cardiac Monitor (ICM) system providing continuous cardiac monitoring for up to 6 years. Fitbit's Loss of Pulse Detection is a software feature on compatible wearable devices that utilizes PPG and accelerometry sensors for real-time detection of a potential acute event.
Assert-IQu2122 provides advanced arrhythmia detection algorithms, transmits data via Bluetoothu00ae Low Energy to a secure cloud-based data platform, and generates proactive clinician alerts. Fitbit's Loss of Pulse Detection uses PPG and accelerometry to detect a potential loss of pulse and primarily alerts the user and emergency services, with no explicit mention of a clinician-facing data platform for ongoing review.
With Assert-IQu2122, patients can use a patient activator for symptom logging. Fitbit's Loss of Pulse Detection is an opt-in feature for user control and provides haptic and audio alerts directly to the user, automatically calling emergency services if the user is unresponsive.
Assert-IQu2122 is a minimally invasive insertable cardiac monitor. Fitbit's Loss of Pulse Detection is a software-only mobile medical application integrated into a non-invasive wearable smartwatch, such as the Pixel Watch 3.
Assert-IQu2122 targets patients with suspected heart rhythm disorders requiring long-term diagnosis and management. Fitbit's Loss of Pulse Detection is intended for general users of compatible smartwatches who opt-in for a safety feature that can detect a potential loss of pulse and call emergency services.
Assert-IQu2122 provides proactive clinician alerts based on its advanced arrhythmia detection algorithms. Fitbit's Loss of Pulse Detection primarily alerts the user and, if the user is unresponsive, automatically contacts emergency services and shares location; there is no explicit mention of direct clinician alerts.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Assert-IQ or Loss of Pulse Detection

Backers

Who funded each tool's parent company.

Loss of Pulse Detection

AI Tool Finder
AI-powered search. Results may not be comprehensive.